Vitruvian Networks has been formed by GE Ventures and Mayo Clinic to develop a gene therapy software and manufacturing platform.
GE Ventures, the corporate venturing arm of industrial product maker General Electric, and medical research company Mayo Clinic launched a US-based cell and gene data platform called Vitruvian Networks this week.
Vitruvian intends to build a cloud-ready software and manufacturing platform that incorporates business intelligence and data analytics technology to serve gene therapy companies.
The company will initially concentrate on producing autologous cell therapies to treat blood cancers. It will combine Mayo Clinic’s biomarker, cell therapy and clinical outcome data…
